Premaquick Pre-induction Cervical Assessmen Trial

Insulin-like growth factor binding protein-1(A and B)/interleukin-6 (Premaquick®) and Bishop score for pre-induction cervical assessment at term: a randomized control trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201604001592143

Enrollment

170

Registered

2016-04-16

Start date

2016-05-02

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Premaquick

Bishop score

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women scheduled for induction of labor at or beyond 37 weeks of gestation Singleton pregnancy Cephalic presentation Intact membranes Unfavourable cervix (Bishop score <6)

Exclusion criteria

Exclusion criteria: Non-vertex presentation Uterine scars other than one prior low transverse cesarean section Multiple gestation Premature rupture of membranes.

Design outcomes

Primary

Measure	Time frame
percentage of women with unripe cervix, i.e. the percentage of women who will be administered prostaglandin (misoprostol) as a preinduction agent;interval from start of induction to any type of delivery;Uterine rupture	—

Secondary

Measure	Time frame
Need for oxytocin augmentation;Interval from start of induction to beginning of active phase;Number of women with spontaneous rupture of membranes and interval from start of induction to this event;Route of delivery;Number of women with cesarean section for failed induction;Meconium passage;Birth weight;Apgar scores;Number of infants admitted to neonatal intensive care unit	—

Countries

Nigeria

Contacts

Public ContactEUZEBUS EZUGWU

University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu

ezugwueuzebus@yahoo.com+2348037020295

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Mar 6, 2026